BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28245371)

  • 41. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
    Liu W; Hu S; Konopleva M; Khoury JD; Kalhor N; Tang G; Bueso-Ramos CE; Jorgensen JL; Lin P; Medeiros LJ; Lu X
    Pediatr Hematol Oncol; 2015; 32(8):535-47. PubMed ID: 26558423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia].
    Fan JJ; Chai YH; Hu SY; He HL; Zhao WL; Wang Y; Li J; Lu J; Xiao PF; Sun YN; Wang W; Cao L
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):523-6. PubMed ID: 24267134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multi-center trial based on SCMC-ALL-2005 for children's acute lymphoblastic leukemia].
    SHAQ Multicenter Study Group of Children's Acute Lymphoblastic Leukemia Research
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):495-501. PubMed ID: 24267129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.
    Eapen M; Zhang MJ; Devidas M; Raetz E; Barredo JC; Ritchey AK; Godder K; Grupp S; Lewis VA; Malloy K; Carroll WL; Davies SM; Camitta BM; ;
    Leukemia; 2008 Feb; 22(2):281-6. PubMed ID: 18033318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M
    Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
    Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The expression and clinical significance of early differentiation antigens in acute leukemia].
    Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
    Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience.
    Mussolin L; Buldini B; Lovisa F; Carraro E; Disarò S; Lo Nigro L; d'Amore ES; Pillon M; Basso G
    Pediatr Blood Cancer; 2015 Nov; 62(11):1906-13. PubMed ID: 26109265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis].
    Sun NN; Gan SL; Sun H; Zhang QT; Liu YF; Xie XS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):339-42. PubMed ID: 23628028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum to "Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131".
    Cancer; 2021 Nov; 127(21):4106-4107. PubMed ID: 34292579
    [No Abstract]   [Full Text] [Related]  

  • 58. Determining the climatic limitations of a children's cancer common in Africa.
    BURKITT D
    Br Med J; 1962 Oct; 2(5311):1019-23. PubMed ID: 14017064
    [No Abstract]   [Full Text] [Related]  

  • 59. [Significance of procalcitonin in children's non-bacterial infectious diseases].
    Lin ZH; Cai XY; Lin GY
    Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):873-876. PubMed ID: 29141324
    [No Abstract]   [Full Text] [Related]  

  • 60. The Poor Children's Palace of Desire.
    Hospital (Lond 1886); 1920 Jan; 67(1752):315-317. PubMed ID: 29842502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.